A.O.U. Policlinico di Modena

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Crohn's disease1 trial
• Gastric and oesophageal cancer1 trial
• Heart failure1 trial
• Kidney cancer1 trial
• Metastatic breast cancer1 trial
• Systemic sclerosis (scleroderma)1 trial
• Ulcerative colitis1 trial

Phase

• Phase 34 trials
• Phase 21 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Daiichi Sankyo2 trials
• Eisai Inc.1 trial
• Mediar Therapeutics Inc.1 trial
• Takeda1 trial
• Vifor (International) Inc.1 trial

Running trials

• Recruiting

  Evaluation of MTX-474 in Participants with Diffuse Cutaneous Systemic Sclerosis (dcSSc)

  2025-523288-39-00· Phase 2· Mediar Therapeutics Inc.· Source

• Recruiting

  Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

  NCT06731478· Phase 3· Daiichi Sankyo· Source

• Active, not recruiting

  Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

  NCT02811861· Phase 3· Eisai Inc.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Gastric and oesophageal cancer1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Closed trials

• Completed

  Cardiovascular and Renal Treatment in Heart Failure Patients With Hyperkalaemia or at High Risk of Hyperkalaemia

  NCT04864795· Vifor (International) Inc.· Source

• Completed

  DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

  NCT03523585· Phase 3· Daiichi Sankyo· Source

• Completed

  A Study of Long-term Effects of Vedolizumab Subcutaneous in Adults With Ulcerative Colitis and Crohn's Disease

  NCT02620046· Phase 3· Takeda· Source